Press Release

Pages Tagged with "Press Release"

City of Hope research featuring the successful treatment of the oldest patient to achieve remission for leukemia and HIV published in The New England Journal of Medicine (NEJM)
The case demonstrates that older adults with blood cancers who receive reduced intensity chemotherapy before a stem cell transplant with donor cells that are resistant to HIV may be cured...
City of Hope preclinical study uncovers two proteins’ crucial role in causing cancer cell growth
Scientists identify treatment target that disrupts proteins’ interaction, offering hope for new therapeutic approach CONTACTZen Logsdon626-409-9367zlogsdon@coh.orgFINDINGSScientists at City of Hope®, one of the largest...
City of Hope appoints Kristin Higgins, M.D., as chief clinical officer at City of Hope Cancer Center Atlanta
City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Kristin Higgins, M.D., as the chief clinical officer at...
City of Hope, TGen researchers develop machine-learning tool to detect cancer earlier via liquid biopsy
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws CONTACTZen LogsdonCity of Hope626-409-9367zlogsdon@coh.org...
City of Hope research reveals an immune cell that can attack cancer
 Preclinical findings reported in the journal Cell could lead to a new type of immunotherapy CONTACTLetisia Marquez626-476-7593lemarquez@coh.orgLOS ANGELES — According to preclinical research published online...
City of Hope Children’s Cancer Center, Children’s Oncology Group conduct largest clinical trial seeking to prevent heart failure among childhood cancer survivors
Results suggest that more childhood cancer survivors may benefit from a heart-saving medication called carvedilol, even long after their cancer treatment is overCONTACTZen Logsdon626-409-9367zlogsdon@coh.org  Saro H. Armenian, D.O., M.P.H.
Eight cancer survivors celebrate life and perseverance on City of Hope’s Rose Parade float
•    2024 marks the 50th anniversary of City of Hope’s participation in the Rose Parade®•    City of Hope’s float “A Lovely Day for Hope” features patients who overcame unique obstacles to...
City of Hope presents research at American Society of Hematology conference on mosunetuzumab plus polatuzumab vedotin for patients with relapsed or refractory large B cell lymphoma
The research also published simultaneously in Nature MedicineCONTACTLetisia Marquezlemarquez@coh.org(626) 476-7593LOS ANGELES -- New therapies for patients with relapsed or drug-resistant large B cell lymphoma remain...
City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias
Revumenib met its primary endpoint for efficacy in pivotal Phase 2 AUGMENT-101 trial and demonstrated favorable safety and tolerability in adult and pediatric patients with relapsed/refractory KMT2A-rearranged (KMT2Ar) acute myeloid...
City of Hope scientists present promising new research at American Society of Hematology Annual Meeting
CONTACTLetisia Marquez626-476-7593lemarquez@coh.orgResearch addresses potential blood-cancer immunotherapies, DNA vaccines and treatments aimed at preventing CAR T  cell therapy relapse and resistanceLOS ANGELES — Physicians and scientists...